Evista Tablets 60 mg (Raloxifene Hydrochloride)

Adult dose

Administer 60 mg orally once daily as Raloxifene Hydrochloride.

This medication may increase the risk of venous thromboembolism, which occurs when blood clots in the veins block blood vessels. If limited movement occurs while taking this medication, it should be stopped, and may be restarted once symptoms improve. Caution is required in patients with impaired liver function as the concentration of this medication may increase, and regular monitoring of liver function test results is necessary. Use is not recommended in premenopausal women. It should not be used for the prevention of cardiovascular diseases and should be administered cautiously in patients at risk of stroke. Women who are pregnant, may become pregnant, or are breastfeeding should not take this medication as it could be harmful to the fetus or infant. Patients with a history of thrombosis, liver disease, uterine bleeding, or endometrial cancer should avoid this medication. Patients with high triglycerides or impaired kidney function should use this medication carefully. During treatment, facial flushing, leg cramps, peripheral edema, and cold-like symptoms may occur. Some medications may interact with this medication, so patients should inform their healthcare provider of any other medications they are taking. This medication is used for the treatment and prevention of osteoporosis in postmenopausal women and is not intended for men or children. Overdosage may cause symptoms such as dizziness or leg cramps, so caution should be exercised. Store out of reach of children and do not transfer to other containers for safety.

Serious side effects

Venous thrombosis, pulmonary embolism, retinal vein thrombosis, superficial venous thrombophlebitis, venous thromboembolism, arterial thromboembolism, retinal vein occlusion, stroke, mortality related to venous thromboembolism, thrombocytopenia, increased mortality from stroke

Mild side effects

• Vasodilation (facial flushing)
• leg cramps
• cold symptoms
• peripheral edema
• slight decrease in platelet count
• moderate increase in AST and/or ALT
• gallstones
• vaginal bleeding
• itching
• palpitations

This medication should be stored in a tightly closed container to prevent air or moisture from entering and kept at room temperature between 15 to 30 degrees Celsius. Proper storage helps maintain the effectiveness of the medication.

Appearance

White oval coated tablet

Package unit

28 tablets/box